A Phase 2 Study of Sirolimus for Injection (Albumin-bound) in Patients With Progressive or Symptomatic Epithelioid Hemangioendothelioma

NCT07684287 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Epithelioid Hemangioendothelioma

Interventions

DRUG: Sirolimus for injection (Albumin-bound)

Sponsor

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.